High-risk category for early annual ophthalmology screening of patients receiving hydroxychloroquine
- PMID: 29132868
- DOI: 10.1016/j.jaad.2017.07.061
High-risk category for early annual ophthalmology screening of patients receiving hydroxychloroquine
Comment in
-
Reply to: "High risk category for early annual ophthalmology screening on hydroxychloroquine".J Am Acad Dermatol. 2017 Dec;77(6):e173. doi: 10.1016/j.jaad.2017.08.055. J Am Acad Dermatol. 2017. PMID: 29132869 No abstract available.
Comment on
-
Updated recommendations on the use of hydroxychloroquine in dermatologic practice.J Am Acad Dermatol. 2017 Jun;76(6):1176-1182. doi: 10.1016/j.jaad.2017.01.012. Epub 2017 Mar 17. J Am Acad Dermatol. 2017. PMID: 28318681 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
